Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Clinician perceptions, expectations, and management of negative symptoms in schizophrenia.

Marder SR.

J Clin Psychiatry. 2013 Jan;74(1):e01. doi: 10.4088/JCP.12045tx4c.

2.

Comorbid anxiety in patients with psychosis.

Dernovsek MZ, Sprah L.

Psychiatr Danub. 2009 Sep;21 Suppl 1:43-50. Review.

PMID:
19789484
3.

[Negative symptoms, depression, anxiety and alexithymia in DSM III-R schizophrenic patients].

Nkam I, Langlois-Thery S, Dollfus S, Petit M.

Encephale. 1997 Jul-Aug;23(4):267-72. French.

PMID:
9417392
4.

Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia.

Strous RD, Maayan R, Lapidus R, Stryjer R, Lustig M, Kotler M, Weizman A.

Arch Gen Psychiatry. 2003 Feb;60(2):133-41.

PMID:
12578430
5.

[Pharmacological management of anxiety in patients suffering from schizophrenia].

Baylé FJ, Blanc O, De Chazeron I, Lesturgeon J, Lançon C, Caci H, Garay RP, Llorca PM.

Encephale. 2011 May;37 Suppl 1:S83-9. doi: 10.1016/j.encep.2010.08.009. Epub 2010 Oct 12. Review. French.

PMID:
21600338
6.

[Prodromal symptoms in schizophrenic relapse: A descriptive and comparative study].

Bouhlel S, Jones Y, Khelifa E, Msolly M, Melki W, El-Hechmi Z.

Encephale. 2012 Oct;38(5):397-403. doi: 10.1016/j.encep.2011.12.005. Epub 2012 Mar 3. French.

PMID:
23062453
7.

Anticipatory pleasure skills training: a new intervention to reduce anhedonia in schizophrenia.

Favrod J, Giuliani F, Ernst F, Bonsack C.

Perspect Psychiatr Care. 2010 Jul;46(3):171-81. doi: 10.1111/j.1744-6163.2010.00255.x.

PMID:
20591125
8.

Antidepressant usage in schizophrenia.

Plasky P.

Schizophr Bull. 1991;17(4):649-57. Review.

PMID:
1687176
9.

Optimizing treatment of schizophrenia. Enhancing affective/cognitive and depressive functioning.

Ginsberg DL, Schooler NR, Buckley PF, Harvey PD, Weiden PJ.

CNS Spectr. 2005 Feb;10(2):1-13; discussion 14-15.

PMID:
15803622
10.

Relationships between anhedonia, depression, and schizophrenia.

Loas G.

J Nerv Ment Dis. 2002 Oct;190(10):717-8; author reply 718-9. No abstract available.

PMID:
12409870
11.

Long-term treatment of mood disorders in schizophrenia.

Azorin JM.

Acta Psychiatr Scand Suppl. 1995;388:20-3. Review.

PMID:
7541599
12.

Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects.

Hofer A, Kemmler G, Eder U, Edlinger M, Hummer M, Fleischhacker WW.

J Clin Psychiatry. 2004 Jul;65(7):932-9.

PMID:
15291682
14.

Recognizing primary vs secondary negative symptoms and apathy vs expression domains.

Kirkpatrick B.

J Clin Psychiatry. 2014 Apr;75(4):e09. doi: 10.4088/JCP.13049tx3c. Review.

15.

Clinical evaluation of negative symptoms in schizophrenia.

Möller HJ.

Eur Psychiatry. 2007 Sep;22(6):380-6. Epub 2007 May 23.

PMID:
17524626
16.

Negative symptoms and affective disturbance in schizophrenia and related disorders.

Malla AK.

Can J Psychiatry. 1995 Sep;40(7 Suppl 2):S55-9. Review.

PMID:
8564918
17.

Anxiety, depression, and psychosis in Parkinson's disease: unmet needs and treatment challenges.

Chen JJ.

Neurol Clin. 2004 Oct;22(3 Suppl):S63-90. Review. No abstract available.

PMID:
15501367
18.

Clinical correlates of anhedonia and perceptual aberration in first-episode patients with schizophrenia and affective disorder.

Katsanis J, Iacono WG, Beiser M, Lacey L.

J Abnorm Psychol. 1992 Feb;101(1):184-91.

PMID:
1537965
19.

Physician observations and perceptions of positive and negative symptoms of schizophrenia: a multinational, cross-sectional survey.

Lecrubier Y, Perry R, Milligan G, Leeuwenkamp O, Morlock R.

Eur Psychiatry. 2007 Sep;22(6):371-9. Epub 2007 May 23.

PMID:
17521890
20.

New trends in the treatment of anxiety disorders.

Brawman-Mintzer O, Yonkers KA.

CNS Spectr. 2004 Aug;9(8 Suppl 7):19-27. Review.

PMID:
15303077

Supplemental Content

Support Center